Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
U.S. Stem Cell, Inc. [US90350U1007/USRM]   
[01/09/2022]

U.S. Stem Cell, Inc. : Court Reports Favorable Judgment in California Stem Cell Case

SUNRISE, FL / ACCESSWIRE / September 1, 2022 / U.S. Stem Cell, Inc. OTC:USRM, a leader in the development of proprietary, physicianbased stem cell therapies and novel regenerative medicine solutions, is pleased to announce the longawaited favorable ruling of the contemporaneous stem cell case against Cell Surgical Network, a stem cell company involved in a similar stem procedure as U.S. Stem Cell... Lire le communiqué
 
U.S. Stem Cell, Inc. [US90350U1007/USRM]   
[09/03/2022]

U.S. Stem Cell, Inc. : Mark Borman Appointed Chairman of the Board of USRM

SUNRISE, FL / ACCESSWIRE / March 9, 2022 / U.S. Stem Cell, Inc. OTC PINK:USRM, a leader in the development of proprietary, physicianbased stem cell therapies and novel regenerative medicine solutions has appointed Mark Borman as Chairman of the Board as Dr. William P. Murphy Jr transitions to Chairman Emeritus."Mark Borman brings the best of both smallenterprise experience and largecompany... Lire le communiqué
 


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de U.S. St...